| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.005 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.007 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.097 | 0.007 |